A carregar...

Medicare Part D Benzodiazepine Exclusion and Use of Psychotropic Medication by Patients With New Anxiety Disorders

OBJECTIVE: The Medicare Modernization Act (MMA) specifically excluded benzodiazepines from Medicare Part D coverage starting in 2006; however, benzodiazepines are an effective, low-cost treatment for anxiety. This study evaluated the effect of the Medicare Part D benzodiazepine coverage exclusion am...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychiatr Serv
Main Authors: Ong, Michael K., Zhang, Lily, Xu, Haiyong, Azocar, Francisca, Ettner, Susan L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402160/
https://ncbi.nlm.nih.gov/pubmed/22549332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ps.201100331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!